Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

Clinical trial NCT07145255 · RECRUITING

Trial details

NCT number: NCT07145255
Sponsor: MBrace Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Castration-resistant Prostate Cancer Breast Cancer Colo-rectal Cancer Lung Cancer (Non-Small Cell)Pancreas Cancer, Duct Cell Adenocarcinoma

Start date: 2025-09-03
Primary completion: 2029-09-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.